[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336536-105":59,"doc-detail-336536-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","visualizing-cancer-resistance-via-nanoquenching-and-recovery-detector-of-cd44","Visualizing cancer resistance via nanoquenching and recovery detector of CD44","","Drug resistance to chemotherapy remains a major clinical challenge, with CD44 implicated in cellular adhesion, migration, growth, and tumor recurrence. Existing approaches lack accurate, safe, and real-time dynamic monitoring of CD44 expression for managing drug-resistant cancers. This study develops a nanoquenching and recovery detector (Cy3-AptCD44@BPNSs) whose fluorescence recovery reflects CD44 levels, enabling precise, dynamic evaluation of drug resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/visualizing-cancer-resistance-via-nanoquenching-and-recovery-detector-of-cd44/336536/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/visualizing-cancer-resistance-via-nanoquenching-and-recovery-detector-of-cd44/336536.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the Cy3-AptCD44@BPNSs detector report CD44 expression levels?","Question",{"text":112,"@type":113},"Its fluorescence recovery is directly related to CD44 expression on cancer cells. Higher CD44 expression corresponds to a stronger fluorescence recovery signal.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the study’s key finding about downregulating CD44?",{"text":117,"@type":113},"Downregulating CD44 on cancer cells decreases the detector’s fluorescence intensity. This allows dynamic monitoring of CD44 changes.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are traditional CD44 detection methods limited for real-time monitoring?",{"text":121,"@type":113},"ELISA, immunohistochemistry, and Western blot are time-consuming and require expensive instruments, and antibody-based approaches face transport and tumor-penetration limitations due to antibody size.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336536,1790820301,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Zeng et al. Journal of Nanobiotechnology (2024) 22:452  \n[https://doi.org/10.1186/s12951-024-02732-w](https://doi.org/10.1186/s12951-024-02732-w)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \nVisualizing cancer resistance via nanoquenching and recovery detector of CD44  \nJialin Zeng 1†, Lihua Yang2†, Lingke Zeng3, Chengyu Feng2, Yuepeng Yang4, Yingying Ye4, Wenxin Zhang2*, Jian He5* and Chao Zhang 1*  \nAbstract  \nDrug resistance to chemotherapy in cancers remains significant clinical challenges. CD44 modulates cellular adhesion, migration and growth, which plays a pivotal role in driving cancer resistance and even recurrence. Despite ongoing efforts, accurate, safe, and real-time dynamic monitoring techniques for CD44 expression remain inadequate in guiding the management of drug-resistant cancer treatment. In this study, we developed a nanoquenching and recovery detector of CD44 (Cy3-AptCD44@BPNSs) for visualizing cancer drug resistance. The fluorescence recovery of the detector is directly related to the CD44 expression level on cancer cells, which can be used to indicate the degree of drug resistance. It’s confirmed that downregulating CD44 expression on cancer cells results in a corresponding decrease in the fluorescence intensity of the detector, which enables precise and dynamic monitoring of CD44 . In addition, the Cy3-AptCD44@BPNSs also exhibited specificity in detecting CD44 . This visualizing strategy may open up a wide range of possibilities for rapid recognition to cancer drug resistance, which is more efficient and flexible.  \nKeywords Cancer resistance, CD44, Black phosphorus nanosheets (BPNSs), Aptamer, Nano-quenching and recovery detector  \n†Jialin Zeng, Lihua Yang these authors contributed equally to this work.  \n*Correspondence: Wenxin Zhang [zwxsakura@gmail.com](zwxsakura@gmail.com)[ ](zwxsakura@gmail.com)Jian He [hjxueren@126.com](hjxueren@126.com)[ ](hjxueren@126.com)Chao Zhang [czhangsinap@163.com](czhangsinap@163.com)  \n1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China  \n2Department of Pediatric Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China 3Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China  \n4The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510282, Guangdong, China  \n5Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China  \nIntroduction  \nCancer resistance is the ability of cancer cells to withstand the effects of cancer treatment, such as chemotherapy, radiotherapy, or targeted therapy. This can make it difficult to treat cancer and lead to clinical failure [1–3]. Recent studies indicate that the overexpression of CD44 sharply hinders the cytotoxic effects of chemotherapy drugs [4, 5]. CD44, a transmembrane glycoprotein capable of modulating a range of genes involved in cellular adhesion, migration, growth and differentiation, is also associated with drug resistance, metastasis, and tumor recurrence [6]. As a shared receptor as well as cytokine for numerous other extracellular matrix (ECM) components and growth factors, CD44 underlies the expression of phenotypes on the resistance to chemotherapy [4, 7–9]. Furthermore, the role of CD44 in maintaining stem cell properties and tumor stem cells in tumor  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from t","cbCaiffwkJE46pvz","https://ap.wps.com/l/cbCaiffwkJE46pvz","pdf",4541086,11,"English","# Abstract\n## Introduction\n## Conventional approaches for detecting CD44","[{\"question\":\"How does the Cy3-AptCD44@BPNSs detector report CD44 expression levels?\",\"answer\":\"Its fluorescence recovery is directly related to CD44 expression on cancer cells. Higher CD44 expression corresponds to a stronger fluorescence recovery signal.\"},{\"question\":\"What is the study’s key finding about downregulating CD44?\",\"answer\":\"Downregulating CD44 on cancer cells decreases the detector’s fluorescence intensity. This allows dynamic monitoring of CD44 changes.\"},{\"question\":\"Why are traditional CD44 detection methods limited for real-time monitoring?\",\"answer\":\"ELISA, immunohistochemistry, and Western blot are time-consuming and require expensive instruments, and antibody-based approaches face transport and tumor-penetration limitations due to antibody size.\"}]","Visualizing cancer resistance via nanoquenching and recovery detector of CD44 | PDF",1790015491,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a99672edfcb7fddf845ef456abb4158f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c202bc97c6035db6afbd6cf0249a8a9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d5ad64c45d41a3c269d9824eb062854.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52e9ba106196b56a09725a29fc0e84b0.webp",980,1306]